1.
Ahmadian Davoudi S, Hashemi M, Heshmati M, Jebali A, Entezari M. Development and Experimental Evaluation of a Multi-Epitope Nanolipopeptide Platform Targeting PD-1, PD-L1, and HER2 for Gastric Adenocarcinoma Immunotherapy. Arch Adv Biosci [Internet]. 2026 Sep. 30 [cited 2026 Oct. 15];17(1):1-15. Available from: https://journals.sbmu.ac.ir/aab/article/view/52476